PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Arnold, Douglas L.
TI  - Relapsing-Remitting Multiple Sclerosis Effectively Treated with Peginterferon Beta-1
DP  - 2014 Jul 01
TA  - MD Conference Express
PG  - 10--11
VI  - 14
IP  - 6
4099  - http://mdc.sagepub.com/content/14/6/10.short
4100  - http://mdc.sagepub.com/content/14/6/10.full
AB  - Significantly more subjects with relapsing-remitting multiple sclerosis achieved freedom from measured disease activity when treated with peginterferon beta-1a every 2 weeks compared with those who were treated with peginterferon beta-1a every 4 weeks or placebo. This article presents results from a post hoc analysis of 48-week data from the Efficacy and Safety Study of BIIB017 (PEGylated Interferon Beta-1a) in Participants With Relapsing Multiple Sclerosis trial [ADVANCE; NCT00906399].